Magnesium bisglycinate and sleep: what does the evidence really show?
- 3 hours ago
- 5 min read
Magnesium bisglycinate is not a sleeping pill. A randomised trial published in 2025 found a statistically significant but modest improvement after four weeks among adults who reported poor sleep. That result supports a possibility, not a promise: the average effect was small, the main outcome was self-reported and sleep was not measured objectively. Persistent or severe insomnia therefore deserves appropriate assessment even when someone is considering a magnesium supplement.
Why is magnesium associated with sleep?
Magnesium contributes to normal nervous-system function, normal psychological function and numerous enzyme reactions. These established roles make an involvement in processes surrounding rest biologically plausible. Plausibility alone, however, does not show that a capsule shortens the time needed to fall asleep or treats insomnia. Clinical evidence requires trials comparing a defined ingredient with a placebo, using a clear dose, duration and outcome. Claims about sleep must therefore be kept separate from the authorised nutritional functions of magnesium.
What research showed before the bisglycinate trial
A 2021 systematic review combined three randomised trials involving 151 older adults with insomnia. Compared with placebo, magnesium shortened sleep-onset time by approximately 17 minutes. The increase in total sleep time, around 16 minutes, was not statistically conclusive. The reviewers rated the certainty of the evidence as low to very low because there were few studies and important risks of bias. The trials included forms such as oxide and citrate rather than magnesium bisglycinate, so they cannot answer whether bisglycinate is preferable.
The 2025 trial specifically testing bisglycinate
This double-blind study randomly assigned 155 adults aged 18 to 65 who described their sleep as poor to magnesium bisglycinate or placebo. Participants in the active group took 250 mg of elemental magnesium daily, 30 to 60 minutes before bedtime, for four weeks. Their Insomnia Severity Index score fell by 3.9 points, compared with 2.3 points in the placebo group. The difference narrowly reached the study’s threshold for statistical significance.
A genuine finding, but a small effect
The effect size, expressed as Cohen’s d, was 0.2 and therefore small. The study did not find significant benefits on the other psychological outcomes it assessed. Most participants reported no adverse event and no serious adverse events were attributed to the intervention, but four weeks is too short to resolve every question about long-term use. The principal result came from a questionnaire, not polysomnography or another device that objectively recorded sleep.
Why the result cannot be transferred directly to another formula
The trial preparation provided 250 mg of elemental magnesium and approximately 1.523 g of glycine from bisglycinate. It contained neither taurine nor vitamin B6. By contrast, two capsules of the NovAging formula provide 1,420 mg of magnesium bisglycinate, including 320 mg of elemental magnesium, plus 100 mg of taurine and 1.5 mg of vitamin B6. Differences in dose and composition mean the clinical result cannot be used to guarantee an identical effect from this product.
Does magnesium need to be taken at night?
The 2025 trial administered bisglycinate before bedtime, but it did not compare morning and evening use. It shows that an evening routine was tested, not that night-time dosing is biologically superior. Consistency and digestive tolerance may be more important than the precise time on the clock. NovAging’s directions specify two capsules in the evening with water. Following that instruction is reasonable, but the timing should not be presented as a universal rule proven by a head-to-head trial.
Who might notice a benefit?
The 2025 findings apply to adults who reported poor sleep, not to every person with a diagnosed sleep disorder. Low dietary magnesium might influence response, but exploratory analyses cannot reliably identify a definite “responder” profile. Fatigue, tension and restless sleep do not prove magnesium deficiency. Blood magnesium is also an imperfect indicator of total body stores and needs to be interpreted alongside diet, symptoms, health history and, where appropriate, a clinical assessment.
A supplement is not treatment for chronic insomnia
When sleep problems persist, disrupt daytime functioning or occur several times a week, their cause deserves attention. Possibilities include sleep apnoea, anxiety, pain, medicine effects, alcohol use and an irregular sleep schedule. Cognitive behavioural therapy for insomnia is an evidence-based recommended treatment for chronic insomnia in adults. A supplement may be considered as one part of a routine, but it should not delay assessment or replace treatment suited to the underlying problem.
Tolerance and precautions
The formula provides 320 mg of elemental magnesium per day. EFSA’s tolerable upper intake level is 250 mg/day for readily dissociable magnesium from supplements and fortified foods, based mainly on diarrhoea; it excludes magnesium naturally present in food. The formula’s 320 mg should not be treated as a target, and it should not be stacked with other magnesium supplements.
Supplemental magnesium can cause diarrhoea, nausea or abdominal cramping, including as bisglycinate. Seek professional advice if you have digestive sensitivity or impaired kidney function, as kidney impairment increases the risk of magnesium accumulation.
Magnesium should be separated from certain antibiotics and oral bisphosphonates because it can reduce their absorption.
Pregnancy, breastfeeding, chronic illness, heart conditions or regular medicine use warrant advice from a doctor or pharmacist.
Total vitamin B6 intake should include every supplement used at the same time.
Frequently asked questions
Does magnesium bisglycinate make you fall asleep immediately?
Research does not show an immediate sedative effect comparable with a sleep medicine. The recent direct trial assessed daily supplementation over four weeks.
How long could it take to notice a change?
Four weeks was the duration of the direct trial, not a guaranteed response time. No improvement, worsening symptoms or significant daytime impairment should prompt a review of the approach.
Is bisglycinate better than citrate for sleep?
No robust head-to-head trial shows that either form improves sleep more effectively. Bisglycinate now has one direct trial, while older evidence includes several other magnesium forms.
Can magnesium be combined with melatonin?
The combination should not be automatic. Its relevance depends on the reason for use, medicines and medical history; a pharmacist or doctor can help assess it.
When should a sleep problem be assessed?
Seek advice when sleep problems persist, cause marked daytime sleepiness, occur alongside pauses in breathing or low mood, or substantially affect everyday life.
How long does one NovAging bottle last?
The bottle contains 120 capsules. At the stated serving of two capsules each evening, it provides a 60-day supply.
Editorial methodology
Updated 4 September 2026. This review separates the recognised nutritional functions of magnesium from clinical trial findings and the specific characteristics of the NovAging formula. Effect size, methodological limitations and formulation differences are reported deliberately. The article provides general information and does not replace a medical consultation or personalised treatment.
Comments